Psychiatric comorbidities in cases with Duchenne muscular dystrophy: a case series

Duchenne muscular dystrophy is a hereditary multisystem disease caused by mutations in the dystrophin gene, characterized by proximal muscle weakness in early childhood, generally resulting in death before the age of 20 years. Cognitive and neurobehavioral changes are prevalent in Duchenne muscular dystrophy. Furthermore, psychiatric disorders have been reported. Here we present 12 cases with Duchenne muscular dystrophy, aiming to address psychiatric comorbidities and to examine anxiety and depression levels as well as the quality of life in these cases. Twelve inpatients with Duchenne muscular dystrophy were followed, according to their ages, by an adult psychiatrist or a child and adolescent psychiatrist. Psychiatric examination and detailed psychiatric and medical history-taking were performed. The Hospital Anxiety and Depression Scale (HADS) and the KINDL Questionnaire were administered and family interviews conducted. In 5 cases, comorbid psychiatric diagnoses were present, including depression, obsessive compulsive disorder, and generalized anxiety disorder. Anxiety levels according to the HADS were higher than threshold level in two cases. Alongside cognitive and neurobehavioral changes, psychiatric comorbidities such as depression, obsessive compulsive disorder, or generalized anxiety disorder might be seen in Duchenne muscular dystrophy, as was the case with our patients. At the same time, due to the chronic illness process and disability involved, psychosocial support is needed both for the patient and the family. Therefore, it is important that psychiatry should be part of a holistic treatment approach and that psychiatric support should be provided right from the first years in these cases.

PDF

___

1.Snow WM, Anderson JE, Jakobson LS. Neuropsychological and neurobehavioral functioning in Duchenne muscular dystrophy: a review. Neurosci Biobehav Rev 2013; 37:743-752.

2. Moser H. Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention. Hum Genet 1984; 66:17-40.

3. Yiu EM, Kornberg AJ. Duchenne muscular dystrophy. Neurol India 2008; 56:236-247.

4. Biggar WD. Duchenne muscular dystrophy. Pediatr Rev 2006; 27:83-87.

5. Banihani R, Smile S, Yoon G, Dupuis A, Mosleh M, Snider A, McAdam L. Cognitive and neurobehavioral profile in boys with Duchenne muscular dystrophy. J Child Neurol 2015; 30:1472- 1482.

6. Bresolin N, Castelli E, Comi GP, Felisari G, Bardoni A, Perani D, Grassi F, Turconi A, Mazzucchelli F, Gallotti D, Moggio M, Prelle A, Ausenda C, Fazio G, Scarlato G. Cognitive impairment in Duchenne muscular dystrophy. Neuromuscul Disord 1994; 4:359-369.

7. Ricotti V, Mandy WPL, Scoto M, Pane M, Deconinck N, Messina S, Mercuri E, Skuse DH, Muntoni F. Neurodevelopmental, emotional, and behavioural problems in Duchenne muscular dystrophy in relation to underlying dystrophin gene mutations. Dev Med Child Neurol 2016; 58:77-84.

8. Hendriksen JGM, Vles JS. Neuropsychiatric disorders in males with Duchenne muscular dystrophy: frequency rate of attentiondeficit hyperactivity disorder (ADHD), autism spectrum disorder, and obsessive-compulsive disorder. J Child Neurol 2008; 23:477-481.

9. Zigmond AS, Snaith PR. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67:361-370.

10. Aydemir O. Validity and reliability of Turkish version of Hospital Anxiety and Depression Scale. Turk Psikiyatri Derg 1997; 8:280- 287. (Turkish)

11. Eser E, Yuksel H, Baydur H, Bilge B, Dundar PE, Pala T, Oral A. KIDDO-KINDL (KINDL Adolescent Form) Results for validity and reliability of the Quality of Life Scale – Turkish Version. 1. Symposium for Quality of Life in Health (April 8-10, 2004, Izmir), Program and Abstract Book, 78.

12. Eser E, Yuksel H, Baydur H, Erhart M, Saatli G, Ozyurt BC, Ozcan C, Ravens-Sieberer U. The psychometric properties of the new Turkish generic health-related quality of life questionnaire for children (Kid-KINDL). Turk Psikiyatri Derg 2008; 19:409- 417. (Turkish)

13. Cohen HJ, Molnar GE, Taft LT. The genetic relationship of progressive muscular dystrophy (Duchenne type) and mental retardation. Dev Med Child Neurol 1968; 10:754-765.

14. Leibowitz D, Dubowitz V. Intellect and behaviour in Duchenne muscular dystrophy. Dev Med Child Neurol 1981; 23:577-590.

15. Hinton VJ, De Vivo DC, Fee R, Goldstein E, Stern Y. Investigation of poor academic achievement in children with Duchenne muscular dystrophy. Learn Disabil Res Pract 2004; 19:146-154.

16. Hendriksen JG, Vles JS. Are males with Duchenne muscular dystrophy at risk for reading disabilities? Pediatr Neurol 2006; 34:296-300.

17. Steele M, Taylor E, Young C, McGrath P, Lyttle BD, Davidson B. Mental health of children and adolescents with Duchenne muscular dystrophy. Dev Med Child Neurol 2008; 50:638-639.

18. Pane M, Lombardo ME, Alfieri P, D’Arnico A, Bianco F, Vasco G, Piccini G, Mallardi M, Romeo DM, Ricotti V, Ferlini A, Gualandi F, Vicari S, Bertini E, Berardinelli A, Mercuri E. Attention deficit hyperactivity disorder and cognitive function in Duchenne muscular dystrophy: phenotype-genotype correlation. J Pediatr 2012; 161:705-709.

19.Darke J, Bushby K, Le Couteur A, McConachie H. Survey of behavior problems in children with neuromuscular diseases. Eur J Paediatr Neurol 2006; 10:129-134.

20. Wu JY, Kuban KC, Allred E, Shapiro F, Darras BT. Association of Duchenne muscular dystrophy with autism spectrum disorder. J Child Neurol 2005; 20:790-795.

21. Filippo TD, Parisi L, Roccella M. Psychological aspects in children affected by Duchenne de Boulogne muscular dystrophy. Ment Illn 2014; 4:e5.

22. Roccella M, Pace R, De Gregorio MT. Psychopathological assessment in children affected by Duchenne de Boulogne muscular dystrophy. Minerva Pediatr 2003; 55:267-273.

23. Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 2010; 9:77-93.

24. Uzark K, King E, Cripe L, Spicer R, Sage J, Kinnett K, Wong B, Pratt J, Varni JW. Health-related quality of life in children and adolescents with Duchenne muscular dystrophy. Pediatrics 2012; 130:e1559-1566.

25. Baiardini I, Minetti C, Bonifacino S, Porcu A, Klersy C, Petralia P, Balestracci S, Tarchino F, Parodi S, Canonica GW, Braido F. Quality of life in Duchenne muscular dystrophy: the subjective impact on children and parents. J Child Neurol 2011; 26: 707-713.